ABEO Return on Tangible Equity | ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC. (ABEO) Return on Tangible Equity

2026-06-30: Return Tang Equity -65.79%.
2026-03-31: Return Tang Equity 58.80%.
2025-12-31: Return Tang Equity 56.16%.
2025-09-30: Return Tang Equity 59.34%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-65.79%
2026-03-31	58.80%
2025-12-31	56.16%
2025-09-30	59.34%
2025-06-30	43.66%
2025-03-31	-494.79%
2024-12-31	-551.09%
2024-09-30	-533.79%
2024-06-30	-129.00%
2024-03-31	185.40%
2023-12-31	307.19%
2023-09-30	428.83%
2023-06-30	170.04%
2023-03-31	194.95%
2022-12-31	695.81%
2022-09-30	369.52%
2022-06-30	402.84%
2022-03-31	718.23%
2021-12-31	-997.14%
2021-09-30	-117.91%
2021-06-30	-108.16%
2021-03-31	-86.14%
2020-12-31	-122.82%
2020-09-30	-105.04%
2020-06-30	-109.59%
2020-03-31	-108.11%
2019-12-31	-69.48%
2019-09-30	-296.11%
2019-06-30	-212.58%
2019-03-31	-148.28%
2018-12-31	-96.81%
2018-09-30	-41.77%
2018-06-30	-29.34%
2018-03-31	-24.44%
2017-12-31	-20.44%
2017-09-30	-48.49%
2017-06-30	-44.13%
2017-03-31	-39.19%
2016-12-31	-37.55%
2016-09-30	-76.73%
2016-06-30	-91.03%
2016-03-31	-67.60%
2015-12-31	-50.71%
2015-09-30	-88.18%
2015-06-30	-138.53%
2015-03-31	1626.98%
2014-12-31	15301.71%
2014-09-30	52.41%
2014-06-30	51.40%
2014-03-31	3.17%
2013-12-31	-30.10%
2013-09-30	-192.58%
2013-06-30	-86.14%
2013-03-31	11.46%
2012-12-31	61.68%
2012-09-30	64.57%
2012-06-30	47.37%
2012-03-31	26.98%
2011-12-31	14.09%
2011-09-30	2.14%
2011-06-30	55.64%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	56.78%
2024-12-31	-626.01%
2023-12-31	284.84%
2022-12-31	559.97%
2021-12-31	-997.14%
2020-12-31	-122.82%
2019-12-31	-69.48%
2018-12-31	-96.81%
2017-12-31	-20.44%
2016-12-31	-37.55%
2015-12-31	-50.71%
2014-12-31	15301.71%
2013-12-31	-30.10%
2012-12-31	61.68%
2011-12-31	14.09%
2010-12-31	35.27%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40